Cordis Beats Boston Scientific In Latest Round Of DES Patent Suits
This article was originally published in The Gray Sheet
Executive Summary
A jury will convene in August to set damages for Boston Scientific's infringement of J&J/Cordis' coronary and peripheral stent patents
You may also be interested in...
No Summer Break? Legal, Enforcement Issues Tax Boston Scientific Counsel
Manhattan federal court will determine whether Boston Scientific is entitled to payment from Medinol for lost revenue associated with the Nir Flex stent
No Summer Break? Legal, Enforcement Issues Tax Boston Scientific Counsel
Manhattan federal court will determine whether Boston Scientific is entitled to payment from Medinol for lost revenue associated with the Nir Flex stent
Boston Scientific Suit Says J&J’s Cypher Infringes Patent, Asks For Injunction
Opposing patent infringement claims by Boston Scientific and Johnson & Johnson introduce a level of uncertainty as to which firm will initially capture the lion's share of the U.S. drug-eluting stent market